Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics

Antiviral Research

Volumn 122, Issue , 2015, Pages 91-100

  Guo, Ju Tao ^a   Guo, Haitao ^b  

^a BARUCH S BLUMBERG INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral; cccDNA; DNA repair; Hepatitis B virus; Innate immunity

Indexed keywords

ANTIVIRUS AGENT; CORE PROTEIN; COVALENTLY CLOSED CIRCULAR DNA; ENVELOPE PROTEIN; GENOMIC DNA; HOST FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS DNA; CIRCULAR DNA;

CELL DIVISION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNA METABOLISM; DNA SEQUENCE; DNA STRUCTURE; DNA SYNTHESIS; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LIVER CELL; MINICHROMOSOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; GENETICS; HEPATITIS B, CHRONIC; IMMUNOLOGY; METABOLISM; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS;

ANTIVIRAL AGENTS; DNA, CIRCULAR; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; VIRUS REPLICATION;

EID: 84940183673     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.08.005     Document Type: Review

References (139)

1. W.R. Addison, K.A. Walters, W.W. Wong, J.S. Wilson, D. Madej, L.D. Jewell, and D.L. Tyrrell Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication J. Virol. 76 2002 6356 6363
2. T. Alain, T.S. Kim, X. Lun, A. Liacini, L.A. Schiff, D.L. Senger, and P.A. Forsyth Proteolytic disassembly is a critical determinant for reovirus oncolysis Mol. Ther. 15 2007 1512 1521
3. M.E. Ballestas, P.A. Chatis, and K.M. Kaye Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen Science 284 1999 641 644
4. R. Bartenschlager, and H. Schaller The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription EMBO J. 7 1988 4185 4192
5. L. Belloni, T. Pollicino, F. De Nicola, F. Guerrieri, G. Raffa, M. Fanciulli, G. Raimondo, and M. Levrero Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function Proc. Natl. Acad. Sci. U.S.A. 106 2009 19975 19979
6. C.A. Bill, and J. Summers Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration Proc. Natl. Acad. Sci. U.S.A. 101 2004 11135 11140
7. T.M. Block, R. Gish, H. Guo, A. Mehta, A. Cuconati, W. Thomas London, and J.T. Guo Chronic hepatitis B: what should be the goal for new therapies? Antiviral Res. 98 2013 27 34
8. T.M. Block, H. Guo, and J.T. Guo Molecular virology of hepatitis B virus for clinicians Clin. Liver Dis. 11 vii 2007 685 706
9. K. Bloom, A. Ely, C. Mussolino, T. Cathomen, and P. Arbuthnot Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases Mol. Ther. 21 2013 1889 1897
10. C.T. Bock, P. Schranz, C.H. Schroder, and H. Zentgraf Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell Virus Genes 8 1994 215 229
11. C.T. Bock, S. Schwinn, S. Locarnini, J. Fyfe, M.P. Manns, C. Trautwein, and H. Zentgraf Structural organization of the hepatitis B virus minichromosome J. Mol. Biol. 307 2001 183 196
12. S. Bowden, S. Locarnini, T.T. Chang, Y.C. Chao, K.H. Han, R.G. Gish, R.A. de Man, M. Yu, C. Llamoso, and H. Tang Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine World J. Gastroenterol. 21 2015 4644 4651
13. D. Cai, C. Mills, W. Yu, R. Yan, C.E. Aldrich, J.R. Saputelli, W.S. Mason, X. Xu, J.T. Guo, T.M. Block, A. Cuconati, and H. Guo Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation Antimicrob. Agents Chemother. 56 2012 4277 4288
14. M.P. Calos Stability without a centromere Proc. Natl. Acad. Sci. U.S.A. 95 1998 4084 4085
15. N. Cassano, V. Mastrandrea, M. Principi, F. Loconsole, N. De Tullio, A. Di Leo, and G.A. Vena Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease J. Biol. Regul. Homeost. Agents 25 2011 285 289
16. J. Chen, W. Zhang, J. Lin, F. Wang, M. Wu, C. Chen, Y. Zheng, X. Peng, J. Li, and Z. Yuan An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases Mol. Ther. 22 2014 303 311
17. F.V. Chisari, and C. Ferrari Hepatitis B virus immunopathology Springer Semin. Immunopathol. 17 1995 261 281
18. F.V. Chisari, W.S. Mason, and C. Seeger Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA" Science 344 2014 1237
19. Y.C. Chou, K.S. Jeng, M.L. Chen, H.H. Liu, T.L. Liu, Y.L. Chen, Y.C. Liu, C.P. Hu, and C. Chang Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method J. Virol. 79 2005 1813 1823
20. F. Cortes Ledesma, S.F. El Khamisy, M.C. Zuma, K. Osborn, and K.W. Caldecott A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage Nature 461 2009 674 678
21. X. Cui, J.T. Guo, and J. Hu Hepatitis B virus covalently closed circular dna formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization J. Virol. 2015
22. X. Cui, L. Ludgate, X. Ning, and J. Hu Maturation-associated destabilization of hepatitis B virus nucleocapsid J. Virol. 87 2013 11494 11503
23. X. Cui, R. McAllister, R. Boregowda, J.A. Sohn, F.C. Ledesma, K.W. Caldecott, C. Seeger, and J. Hu Does Tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair? PLoS ONE 10 2015 e0128401
24. M. Dandri, M.R. Burda, H. Will, and J. Petersen Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA Hepatology 32 2000 139 146
25. P.M. Day, D.R. Lowy, and J.T. Schiller Papillomaviruses infect cells via a clathrin-dependent pathway Virology 307 2003 1 11
26. C. Dong, L. Qu, H. Wang, L. Wei, Y. Dong, and S. Xiong Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication Antiviral Res. 118 2015 110 117
27. A. Ducroux, S. Benhenda, L. Riviere, O.J. Semmes, M. Benkirane, and C. Neuveut The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B Virus and herpes simplex virus type 1 PLoS Pathog. 10 2014 e1004343
28. B.K. Ganser-Pornillos, M. Yeager, and W.I. Sundquist The structural biology of HIV assembly Curr. Opin. Struct. Biol. 18 2008 203 217
29. W. Gao, and J. Hu Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein J. Virol. 2007
30. W.H. Gerlich, and W.S. Robinson Hepatitis B virus contains protein attached to the 5′ terminus of its complete DNA strand Cell 21 1980 801 809
31. P. Gripon, S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo Infection of a human hepatoma cell line by hepatitis B virus Proc. Natl. Acad. Sci. U.S.A. 99 2002 15655 15660
32. L.G. Guidotti, B. Matzke, H. Schaller, and F.V. Chisari High-level hepatitis B virus replication in transgenic mice J. Virol. 69 1995 6158 6169
33. L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection [In Process Citation] Science 284 1999 825 829
34. H. Guo, D. Jiang, T. Zhou, A. Cuconati, T.M. Block, and J.T. Guo Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation J. Virol. 81 2007 12472 12484
35. H. Guo, R. Mao, T.M. Block, and J.T. Guo Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses J. Virol. 84 2010 387 396
36. H. Guo, C. Xu, T. Zhou, T.M. Block, and J.T. Guo Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation PLoS ONE 7 2012 e43270
37. J.-T. Guo, H. Zhou, C. Liu, C. Aldrich, J. Saputelli, T. Whitaker, M.I. Barrasa, W.S. Mason, and C. Seeger Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infection J. Virol. 74 2000 1495 1505
38. J.T. Guo, M. Pryce, X. Wang, M.I. Barrasa, J. Hu, and C. Seeger Conditional replication of duck hepatitis B virus in hepatoma cells J. Virol. 77 2003 1885 1893
39. Y.H. Guo, Y.N. Li, J.R. Zhao, J. Zhang, and Z. Yan HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state Epigenetics 6 2011 720 726
40. W. He, B. Ren, F. Mao, Z. Jing, Y. Li, Y. Liu, B. Peng, H. Yan, Y. Qi, Y. Sun, J.T. Guo, J. Sui, F. Wang, and W. Li Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide PLoS Pathog. 11 2015 e1004840
41. K.A. Hoeksema, and D.L. Tyrrell Inhibition of viral transcription using designed zinc finger proteins Methods Mol. Biol. 649 2010 97 116
42. S.C. Hung, M.S. Kang, and E. Kieff Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1 Proc. Natl. Acad. Sci. U.S.A. 98 2001 1865 1870
43. M. Iwamoto, K. Watashi, S. Tsukuda, H.H. Aly, M. Fukasawa, A. Fujimoto, R. Suzuki, H. Aizaki, T. Ito, O. Koiwai, H. Kusuhara, and T. Wakita Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP Biochem. Biophys. Res. Commun. 443 2014 808 813
44. H.L. Janssen, M. van Zonneveld, H. Senturk, S. Zeuzem, U.S. Akarca, Y. Cakaloglu, C. Simon, T.M. So, G. Gerken, R.A. de Man, H.G. Niesters, P. Zondervan, B. Hansen, and S.W. Schalm Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 365 2005 123 129
45. A.R. Jilbert, T.T. Wu, J.M. England, P.M. Hall, N.Z. Carp, A.P. O'Connell, and W.S. Mason Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement J. Virol. 66 1992 1377 1388
46. K. Kajino, A.R. Jilbert, J. Saputelli, C.E. Aldrich, J. Cullen, and W.S. Mason Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte J. Virol. 68 1994 5792 5803
47. M. Kann, B. Sodeik, A. Vlachou, W.H. Gerlich, and A. Helenius Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex J. Cell Biol. 145 1999 45 55
48. E.B. Keeffe, D.T. Dieterich, S.H. Han, I.M. Jacobson, P. Martin, E.R. Schiff, and H. Tobias A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update Clin. Gastroenterol. Hepatol. 6 2008 1315 1341 quiz 1286
49. J.W. Kim, S.H. Lee, Y.S. Park, J.H. Hwang, S.H. Jeong, N. Kim, and D.H. Lee Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection Intervirology 54 2011 316 325
50. C. Koniger, I. Wingert, M. Marsmann, C. Rosler, J. Beck, and M. Nassal Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses Proc. Natl. Acad. Sci. U.S.A. 111 2014 E4244 E4253
51. S.K. Ladner, M.J. Otto, C.S. Barker, K. Zaifert, G.H. Wang, J.T. Guo, C. Seeger, and R.W. King Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication Antimicrob. Agents Chemother. 41 1997 1715 1720
52. A. Laras, J. Koskinas, E. Dimou, A. Kostamena, and S.J. Hadziyannis Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients Hepatology 44 2006 694 702
53. G.K. Lau, T. Piratvisuth, K.X. Luo, P. Marcellin, S. Thongsawat, G. Cooksley, E. Gane, M.W. Fried, W.C. Chow, S.W. Paik, W.Y. Chang, T. Berg, R. Flisiak, P. McCloud, and N. Pluck Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N. Engl. J. Med. 352 2005 2682 2695
54. V. Le Sage, A.J. Mouland, and F. Valiente-Echeverria Roles of HIV-1 capsid in viral replication and immune evasion Virus Res. 193 2014 116 129
55. C.W. Lehman, and M.R. Botchan Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation Proc. Natl. Acad. Sci. U.S.A. 95 1998 4338 4343
56. R.J. Lenhoff, C.A. Luscombe, and J. Summers Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus Hepatology 29 1999 563 571
57. R.J. Lenhoff, and J. Summers Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus J. Virol. 68 1994 4565 4571
58. T.B. Lentz, and D.D. Loeb Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus J. Virol. 85 2011 11916 11927
59. M. Levrero, T. Pollicino, J. Petersen, L. Belloni, G. Raimondo, and M. Dandri Control of cccDNA function in hepatitis B virus infection J. Hepatol. 51 2009 581 592
60. Y.F. Liaw Impact of therapy on the outcome of chronic hepatitis B Liver Int. 33 Suppl 1 2013 111 115
61. J.M. Lien, C.E. Aldrich, and W.S. Mason Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis J. Virol. 57 1986 229 236
62. S.R. Lin, H.C. Yang, Y.T. Kuo, C.J. Liu, T.Y. Yang, K.C. Sung, Y.Y. Lin, H.Y. Wang, C.C. Wang, Y.C. Shen, F.Y. Wu, J.H. Kao, D.S. Chen, and P.J. Chen The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo, molecular therapy Nucl. Acids 3 2014 e186
63. F. Liu, M. Campagna, Y. Qi, X. Zhao, F. Guo, C. Xu, S. Li, W. Li, T.M. Block, J. Chang, and J.T. Guo Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes PLoS Pathog. 9 2013 e1003613
64. N. Liu, R. Tian, and D.D. Loeb Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription Proc. Natl. Acad. Sci. U.S.A. 100 2003 1984 1989
65. X. Liu, R. Hao, S. Chen, D. Guo, and Y. Chen Inhibition of hepatitis B Virus by CRISPR/Cas9 system via targeting the conserved regions of viral genome J. Gen. Virol. 2015
66. J. Lucifora, S. Arzberger, D. Durantel, L. Belloni, M. Strubin, M. Levrero, F. Zoulim, O. Hantz, and U. Protzer Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection J. Hepatol. 55 2011 996 1003
67. J. Lucifora, Y. Xia, F. Reisinger, K. Zhang, D. Stadler, X. Cheng, M.F. Sprinzl, H. Koppensteiner, Z. Makowska, T. Volz, C. Remouchamps, W.M. Chou, W.E. Thasler, N. Huser, D. Durantel, T.J. Liang, C. Munk, M.H. Heim, J.L. Browning, E. Dejardin, M. Dandri, M. Schindler, M. Heikenwalder, and U. Protzer Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 343 2014 1221 1228
68. M. Lutgehetmann, T. Volz, A. Kopke, T. Broja, E. Tigges, A.W. Lohse, E. Fuchs, J.M. Murray, J. Petersen, and M. Dandri In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice Hepatology 52 2010 16 24
69. R.A. MacDonald "Lifespan" of liver cells. Autoradio-graphic study using tritiated thymidine in normal, cirrhotic, and partially hepatectomized rats Arch. Intern. Med. 107 1961 335 343
70. Y. Magami, T. Azuma, H. Inokuchi, S. Kokuno, F. Moriyasu, K. Kawai, and T. Hattori Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver Liver 22 2002 419 425
71. W.S. Mason, C. Aldrich, J. Summers, and J.M. Taylor Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA Proc. Natl. Acad. Sci. U.S.A. 79 1982 3997 4001
72. T.C. Mettenleiter, B.G. Klupp, and H. Granzow Herpesvirus assembly: an update Virus Res. 2009
73. K.L. Molnar-Kimber, J. Summers, J.M. Taylor, and W.S. Mason Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus J. Virol. 45 1983 165 172
74. G. Moraleda, J. Saputelli, C.E. Aldrich, D. Averett, L. Condreay, and W.S. Mason Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus J. Virol. 71 1997 9392 9399
75. J.M. Murray, S.F. Wieland, R.H. Purcell, and F.V. Chisari Dynamics of hepatitis B virus clearance in chimpanzees Proc. Natl. Acad. Sci. U.S.A. 102 2005 17780 17785
76. M. Nassal HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B Gut 2015
77. J.E. Newbold, H. Xin, M. Tencza, G. Sherman, J. Dean, S. Bowden, and S. Locarnini The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes J. Virol. 69 1995 3350 3357
78. Y. Ni, F.A. Lempp, S. Mehrle, S. Nkongolo, C. Kaufman, M. Falth, J. Stindt, C. Koniger, M. Nassal, R. Kubitz, H. Sultmann, and S. Urban Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes Gastroenterology 146 2014 1070 1083
79. J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219
80. V. Pattullo Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure World J. Hepatol. 7 2015 954 967
81. R. Perrillo Benefits and risks of interferon therapy for hepatitis B Hepatology 49 2009 S103 S111
82. T. Pollicino, L. Belloni, G. Raffa, N. Pediconi, G. Squadrito, G. Raimondo, and M. Levrero Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones Gastroenterology 130 2006 823 837
83. N.K. Pyzocha, F.A. Ran, P.D. Hsu, and F. Zhang RNA-guided genome editing of mammalian cells Methods Mol. Biol. 1114 2014 269 277
84. B. Rabe, A. Vlachou, N. Pante, A. Helenius, and M. Kann Nuclear import of hepatitis B virus capsids and release of the viral genome Proc. Natl. Acad. Sci. U.S.A. 100 2003 9849 9854
85. V. Ramanan, A. Shlomai, D.B. Cox, R.E. Schwartz, E. Michailidis, A. Bhatta, D.A. Scott, F. Zhang, C.M. Rice, and S.N. Bhatia CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus Sci. Rep. 5 2015 10833
86. A.K. Raney, C.M. Eggers, E.F. Kline, L.G. Guidotti, M. Pontoglio, M. Yaniv, and A. McLachlan Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice J. Virol. 75 2001 2900 2911
87. J. Rasaiyaah, C.P. Tan, A.J. Fletcher, A.J. Price, C. Blondeau, L. Hilditch, D.A. Jacques, D.L. Selwood, L.C. James, M. Noursadeghi, and G.J. Towers HIV-1 evades innate immune recognition through specific cofactor recruitment Nature 503 2013 402 405
88. G.Y. Reaiche-Miller, M. Thorpe, H.C. Low, Q. Qiao, C.A. Scougall, W.S. Mason, S. Litwin, and A.R. Jilbert Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver Virology 446 2013 357 364
89. B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T- lymphocyte response Nat. Med. 2 1996 1104 1108
90. Q. Ren, C. Li, P. Yuan, C. Cai, L. Zhang, G.G. Luo, and W. Wei A Dual-reporter system for real-time monitoring and high-throughput CRISPR/Cas9 library screening of the hepatitis C virus Sci. Rep. 5 2015 8865
91. L. Riviere, L. Gerossier, A. Ducroux, S. Dion, Q. Deng, M.L. Michel, M.A. Buendia, O. Hantz, and C. Neuveut HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase J. Hepatol. 2015
92. K. Schmidt, and B. Korba Hepatitis B virus cell culture assays for antiviral activity Methods Mol. Med. 24 2000 51 67
93. A. Schmitz, A. Schwarz, M. Foss, L. Zhou, B. Rabe, J. Hoellenriegel, M. Stoeber, N. Pante, and M. Kann Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket PLoS Pathog. 6 2010 e1000741
94. U. Schultz, J. Summers, P. Staeheli, and F.V. Chisari Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes J. Virol. 73 1999 5459 5465
95. H. Schulze-Bergkamen, A. Untergasser, A. Dax, H. Vogel, P. Buchler, E. Klar, T. Lehnert, H. Friess, M.W. Buchler, M. Kirschfink, W. Stremmel, P.H. Krammer, M. Muller, and U. Protzer Primary human hepatocytes-a valuable tool for investigation of apoptosis and hepatitis B virus infection J. Hepatol. 38 2003 736 744
96. C. Seeger, and W.S. Mason Molecular biology of hepatitis B virus infection Virology 479-480C 2015 672 686
97. C. Seeger, and J.A. Sohn Targeting hepatitis B virus with CRISPR/Cas9. Molecular therapy Nucl. Acids 3 2014 e216
98. M.A. Sells, M. Chen, and G. Acs Production of hepatitis B virus particles in hepG2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1009
99. M.A. Sells, A.Z. Zelent, M. Shvartsman, and G. Acs Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions J. Virol. 62 1988 2836 2844
100. L. Shi, S. Li, F. Shen, H. Li, S. Qian, D.H. Lee, J.Z. Wu, and W. Yang Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes J. Virol. 86 2012 10059 10069
101. A. Shlomai, and C.M. Rice Virology. Getting rid of a persistent troublemaker to cure hepatitis Science 343 2014 1212 1213
102. J.L. Smith, S.K. Campos, A. Wandinger-Ness, and M.A. Ozbun Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating J. Virol. 82 2008 9505 9512
103. J.A. Sohn, S. Litwin, and C. Seeger Mechanism for CCC DNA synthesis in hepadnaviruses PLoS ONE 4 2009 e8093
104. S. Staprans, D.D. Loeb, and D. Ganem Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA J. Virol. 65 1991 1255 1262
105. J. Summers, A.R. Jilbert, W. Yang, C.E. Aldrich, J. Saputelli, S. Litwin, E. Toll, and W.S. Mason Hepatocyte turnover during resolution of a transient hepadnaviral infection Proc. Natl. Acad. Sci. U.S.A. 100 2003 11652 11659
106. J. Summers, and W.S. Mason Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate Cell 29 1982 403 415
107. J. Summers, A. O'Connell, and I. Millman Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles Proc. Natl. Acad. Sci. U.S.A. 72 1975 4597 4601
108. J. Summers, P.M. Smith, and A.L. Horwich Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification J. Virol. 64 1990 2819 2824
109. J. Summers, P.M. Smith, M.J. Huang, and M.S. Yu Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus J. Virol. 65 1991 1310 1317
110. J.J. Sung, M.L. Wong, S. Bowden, C.T. Liew, A.Y. Hui, V.W. Wong, N.W. Leung, S. Locarnini, and H.L. Chan Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy Gastroenterology 128 2005 1890 1897
111. J. Tavis, and D. Ganem RNA sequences controlling the initiation of duck hepatits B virus minus-strand DNA J. Virol. 69 1995 4283 4291
112. J. Tavis, and D. Ganem Evidence for activation of the hepatitis B virus polymerase by binding of its RNA template J. Virol. 70 1996 5741 5750
113. J.S. Tuttleman, C. Pourcel, and J. Summers Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells Cell 47 1986 451 460
114. R. VirgenSlane, J.M. Rozovics, K.D. Fitzgerald, T. Ngo, W. Chou, G.J. Vander Heden van Noort, D.V. Filippov, P.D. Gershon, and B.L. Semler An RNA virus hijacks an incognito function of a DNA repair enzyme Proc. Natl. Acad. Sci. U.S.A. 109 2012 14634 14639
115. G.H. Wang, and C. Seeger The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis Cell 71 1992 663 670
116. G.H. Wang, and C. Seeger Novel mechanism for reverse transcription in hepatitis B viruses J. Virol. 67 1993 6507 6512
117. N.D. Weber, D. Stone, R.H. Sedlak, H.S. De Silva Feelixge, P. Roychoudhury, J.T. Schiffer, M. Aubert, and K.R. Jerome AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication PLoS ONE 9 2014 e97579
118. B. Werle-Lapostolle, S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, G. Lau, C. Trepo, P. Marcellin, Z. Goodman, W.E.T. Delaney, S. Xiong, C.L. Brosgart, S.S. Chen, C.S. Gibbs, and F. Zoulim Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 2004 1750 1758
119. S.F. Wieland, H.C. Spangenberg, R. Thimme, R.H. Purcell, and F.V. Chisari Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees Proc. Natl. Acad. Sci. U.S.A. 101 2004 2129 2134
120. T.T. Wu, L. Coates, C.E. Aldrich, J. Summers, and W.S. Mason In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway Virology 175 1990 255 261
121. K. Wursthorn, M. Lutgehetmann, M. Dandri, T. Volz, P. Buggisch, B. Zollner, T. Longerich, P. Schirmacher, F. Metzler, M. Zankel, C. Fischer, G. Currie, C. Brosgart, and J. Petersen Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B Hepatology 44 2006 675 684
122. C. Xu, H. Guo, X.B. Pan, R. Mao, W. Yu, X. Xu, L. Wei, J. Chang, T.M. Block, and J.T. Guo Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus J. Virol. 84 2010 9332 9340
123. H. Yan, B. Peng, Y. Liu, G. Xu, W. He, B. Ren, Z. Jing, J. Sui, and W. Li Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide J. Virol. 88 2014 3273 3284
124. H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, H. Wang, L. Fu, M. Song, P. Chen, W. Gao, B. Ren, Y. Sun, T. Cai, X. Feng, J. Sui, and W. Li Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus Elife 1 2012 e00049
125. W. Yang, W.S. Mason, and J. Summers Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver J. Virol. 70 1996 4567 4575
126. W. Yang, and J. Summers Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination J. Virol. 69 1995 4029 4036
127. W. Yang, and J. Summers Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor J. Virol. 73 1999 9710 9717
128. J. You, J.L. Croyle, A. Nishimura, K. Ozato, and P.M. Howley Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes Cell 117 2004 349 360
129. J. You, V. Srinivasan, G.V. Denis, W.J. Harrington Jr., M.E. Ballestas, K.M. Kaye, and P.M. Howley Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes J. Virol. 80 2006 8909 8919
130. F. Zhang, Y. Wen, and X. Guo CRISPR/Cas9 for genome editing: progress, implications and challenges Hum. Mol. Genet. 23 2014 R40 R46
131. Y. Zhang, C. Li, Y. Zhang, H. Zhu, Y. Kang, H. Liu, J. Wang, Y. Qin, R. Mao, Y. Xie, Y. Huang, and J. Zhang Comparative analysis of CpG islands among HBV genotypes PLoS ONE 8 2013 e56711
132. Y. Zhang, R. Mao, R. Yan, D. Cai, Y. Zhang, H. Zhu, Y. Kang, H. Liu, J. Wang, Y. Qin, Y. Huang, H. Guo, and J. Zhang Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection PLoS ONE 9 2014 e110442
133. Y.Y. Zhang, B.H. Zhang, D. Theele, S. Litwin, E. Toll, and J. Summers Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver Proc. Natl. Acad. Sci. U.S.A. 100 2003 12372 12377
134. X.L. Zhao, J.R. Yang, S.Z. Lin, H. Ma, F. Guo, R.F. Yang, H.H. Zhang, J.C. Han, L. Wei, and X.B. Pan Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV Gut 2015
135. T. Zhou, H. Guo, J.T. Guo, A. Cuconati, A. Mehta, and T.M. Block Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays Antiviral Res. 72 2006 116 124
136. Y. Zhu, T. Yamamoto, J. Cullen, J. Saputelli, C.E. Aldrich, D.S. Miller, S. Litwin, P.A. Furman, A.R. Jilbert, and W.S. Mason Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis J. Virol. 75 2001 311 322
137. K.A. Zimmerman, K.P. Fischer, M.A. Joyce, and D.L. Tyrrell Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture J. Virol. 82 2008 8013 8021
138. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 1593-1608 2009 e1591 e1592
139. F. Zoulim, J. Saputelli, and C. Seeger Woodchuck hepatitis virus X protein is required for viral infection in vivo J. Virol. 68 1994 2026 2030